Dr. Azzer provides independent professional pharmaceutical advisory, health-system formulary evaluation, regulatory affairs strategy, and clinical governance consulting services. Consulting engagements and deliverables are formulated for institutional, healthcare network, and biopharmaceutical corporate decision-makers and do not constitute direct patient medical management.
All materials, articles, research summaries, commentaries, and case reviews published on this website are provided strictly for general educational, academic, and professional informational purposes. The information on this site does NOT constitute medical diagnosis, individualized patient treatment recommendations, or personalized prescribing advice.
Browsing this portfolio website, reading published articles, or submitting messages through contact or inquiry forms does not create a pharmacist-patient or healthcare provider-patient relationship. Individual patients seeking personal medical guidance should always consult their personal primary care physician, specialist, or local pharmacist.
While Dr. Azzer advises on federal regulatory frameworks (such as FDA regulations, GCP, GMP, and quality management standards), all formal product clearances, IND/NDA approvals, and institutional authorizations remain under the ultimate jurisdiction of appropriate governmental regulatory bodies and notified authorities.
If you or someone in your care is experiencing an acute medical emergency, please dial 911 or visit your nearest hospital emergency department immediately. This website and its contact mechanisms are not monitored for emergency healthcare communications.